本页面由Tiger Trade Technology Pte. Ltd.提供服务

Viking Therapeutics, Inc.

28.34
-0.1700-0.60%
盘后:28.340.0001+0.00%18:21 EDT
成交量:285.21万
成交额:8,092.81万
市值:35.71亿
市盈率:-6.07
高:28.84
开:28.23
低:27.91
收:28.51
52周最高:43.15
52周最低:25.77
股本:1.26亿
流通股本:1.23亿
量比:0.45
换手率:2.32%
股息:- -
股息率:- -
每股收益(TTM):-4.6676
每股收益(LYR):-3.1920
净资产收益率:-88.85%
总资产收益率:-51.86%
市净率:8.75
市盈率(LYR):-8.88

数据加载中...

2024/03/26

重要事件披露

Form 8-K - Current report
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/26

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/25

重要事件披露

Form 8-K - Current report